Correlation Between ABVC Biopharma and Neoleukin Therapeutics

Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ABVC Biopharma and Neoleukin Therapeutics, you can compare the effects of market volatilities on ABVC Biopharma and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Neoleukin Therapeutics.

Diversification Opportunities for ABVC Biopharma and Neoleukin Therapeutics

0.0

Correlation Coefficient

ABVC Biopharma  Neoleukin Therapeutics

Pay attention - limited upside

The 3 months correlation between ABVC and Neoleukin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Neoleukin Therapeutics go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Neoleukin Therapeutics

If you would invest (100.00) in Neoleukin Therapeutics on November 20, 2024 and sell it today you would earn a total of  100.00  from holding Neoleukin Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

ABVC Biopharma  vs.  Neoleukin Therapeutics

ABVC Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Neoleukin Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neoleukin Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Neoleukin Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with ABVC Biopharma and Neoleukin Therapeutics

The main advantage of trading using opposite ABVC Biopharma and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.

The idea behind ABVC Biopharma and Neoleukin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.